7,8-dihydroxyflavone and its derivatives (Emory University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name7,8-dihydroxyflavone and its derivatives (Emory University)
Drug Alias Name4'-dimethylamino-7,8-dihydroxyflavone (Emory University)7, 8-dihydroxyflayone7,8-dihydroxyflavone7,8-dihydroxyflavone (Emory University/University of Wisconsin)4'-DMA-7,8-DHF
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulants
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsMental DisordersDepressionRett Syndrome +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Yuanzheng Century Pharmaceutical Co LtdUniversity Of Wisconsin-MadisonEmory University
Inactive CompaniesN/A
Active IndicationsDepressionRett SyndromeAmyotrophic Lateral Sclerosis +[4] 
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A